OPTIMUM INVESTMENT ADVISORS - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
OPTIMUM INVESTMENT ADVISORS ownership history of BAXTER INTL INC
ValueSharesWeighting
Q4 2023$10,825
+2.4%
2800.0%0.01%0.0%
Q3 2023$10,567
-17.2%
2800.0%0.01%
-16.7%
Q2 2023$12,757
+12.3%
2800.0%0.01%0.0%
Q1 2023$11,357
-20.4%
2800.0%0.01%
-25.0%
Q4 2022$14,272
-4.9%
2800.0%0.01%0.0%
Q3 2022$15,000
-16.7%
2800.0%0.01%
-11.1%
Q2 2022$18,000
-18.2%
2800.0%0.01%0.0%
Q1 2022$22,000
-8.3%
2800.0%0.01%0.0%
Q4 2021$24,000
+4.3%
2800.0%0.01%
-10.0%
Q3 2021$23,0000.0%2800.0%0.01%
+42.9%
Q2 2021$23,000
-68.9%
280
-68.2%
0.01%
-68.2%
Q1 2021$74,000
+4.2%
8800.0%0.02%0.0%
Q4 2020$71,0000.0%8800.0%0.02%
-8.3%
Q3 2020$71,000
-6.6%
8800.0%0.02%
-7.7%
Q2 2020$76,000
+7.0%
8800.0%0.03%
-10.3%
Q1 2020$71,000
-4.1%
8800.0%0.03%
+31.8%
Q4 2019$74,000
-3.9%
8800.0%0.02%
-8.3%
Q3 2019$77,000
+6.9%
8800.0%0.02%
+4.3%
Q2 2019$72,0000.0%8800.0%0.02%
-4.2%
Q1 2019$72,000
+24.1%
8800.0%0.02%
+20.0%
Q4 2018$58,000
-14.7%
8800.0%0.02%
+5.3%
Q3 2018$68,000
+4.6%
8800.0%0.02%0.0%
Q2 2018$65,000
+14.0%
8800.0%0.02%
+11.8%
Q1 2018$57,000
-59.6%
880
-57.2%
0.02%
-62.2%
Q1 2015$141,000
-19.9%
2,057
-14.5%
0.04%
-21.1%
Q4 2014$176,000
+28.5%
2,407
+26.2%
0.06%
+26.7%
Q3 2014$137,000
-31.5%
1,907
-30.8%
0.04%
-30.8%
Q2 2014$200,000
+50.4%
2,757
+52.6%
0.06%
+30.0%
Q1 2014$133,000
+5.6%
1,8070.0%0.05%
+6.4%
Q4 2013$126,000
+16.7%
1,807
+10.2%
0.05%
+6.8%
Q3 2013$108,0001,6400.04%
Other shareholders
BAXTER INTL INC shareholders Q3 2021
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders